Fairfield, Bush & Co’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.95M | Sell |
19,344
-2,269
| -10% | -$348K | 1.64% | 15 |
|
|
2025
Q4 | $2.98M | Sell |
21,613
-1,241
| -5% | -$163K | 1.57% | 15 |
|
|
2025
Q3 | $2.93M | Sell |
22,854
-1,370
| -6% | -$167K | 1.5% | 17 |
|
|
2025
Q2 | $2.93M | Sell |
24,224
-828
| -3% | -$93.3K | 1.66% | 15 |
|
|
2025
Q1 | $2.79M | Sell |
25,052
-464
| -2% | -$49.4K | 1.77% | 14 |
|
|
2024
Q4 | $2.48M | Buy |
25,516
+567
| +2% | +$60.5K | 1.46% | 17 |
|
|
2024
Q3 | $2.87M | Sell |
24,949
-3,668
| -13% | -$416K | 1.71% | 15 |
|
|
2024
Q2 | $3.05M | Sell |
28,617
-192
| -0.7% | -$19.3K | 1.83% | 13 |
|
|
2024
Q1 | $2.79M | Sell |
28,809
-603
| -2% | -$61.8K | 1.65% | 16 |
|
|
2023
Q4 | $2.97M | Sell |
29,412
-3,924
| -12% | -$379K | 1.74% | 13 |
|
|
2023
Q3 | $3.4M | Sell |
33,336
-7,500
| -18% | -$761K | 2.22% | 11 |
|
|
2023
Q2 | $4.12M | Sell |
40,836
-375
| -0.9% | -$37.5K | 1.13% | 20 |
|
|
2023
Q1 | $3.79M | Buy |
41,211
+7,461
| +22% | +$652K | 1.34% | 20 |
|
|
2022
Q4 | $3.06M | Sell |
33,750
-292
| -0.9% | -$24.6K | 2.02% | 14 |
|
|
2022
Q3 | $2.59M | Sell |
34,042
-3,103
| -8% | -$257K | 1.83% | 16 |
|
|
2022
Q2 | $3.14M | Sell |
37,145
-4,478
| -11% | -$393K | 1.85% | 16 |
|
|
2022
Q1 | $3.65M | Buy |
41,623
+58
| +0.1% | +$5.02K | 1.83% | 15 |
|
|
2021
Q4 | $3.64M | Sell |
41,565
-11,525
| -22% | -$957K | 1.75% | 16 |
|
|
2021
Q3 | $4.34M | Sell |
53,090
-8,804
| -14% | -$792K | 1.41% | 15 |
|
|
2021
Q2 | $5.65M | Sell |
61,894
-3,109
| -5% | -$277K | 1.53% | 17 |
|
|
2021
Q1 | $5.56M | Sell |
65,003
-610
| -0.9% | -$54.7K | 1.59% | 13 |
|
|
2020
Q4 | $6.2M | Hold |
65,613
| – | – | 1.81% | 11 |
|
|
2020
Q3 | $5.71M | Sell |
65,613
-40
| -0.1% | -$3.46K | 1.82% | 12 |
|
|
2020
Q2 | $5.73M | Sell |
65,653
-79
| -0.1% | -$6.82K | 2.05% | 11 |
|
|
2020
Q1 | $5.42M | Sell |
65,732
-1,688
| -3% | -$151K | 2.25% | 10 |
|
|
2019
Q4 | $6.38M | Sell |
67,420
-699
| -1% | -$62.7K | 2.35% | 10 |
|
|
2019
Q3 | $5.92M | Sell |
68,119
-2,962
| -4% | -$266K | 2.05% | 12 |
|
|
2019
Q2 | $6.49M | Sell |
71,081
-16,138
| -19% | -$1.37M | 2.21% | 11 |
|
|
2019
Q1 | $7.51M | Sell |
87,219
-1,102
| -1% | -$88.5K | 2.49% | 10 |
|
|
2018
Q4 | $6.79M | Sell |
88,321
-553
| -0.6% | -$43K | 2.34% | 11 |
|
|
2018
Q3 | $6.86M | Sell |
88,874
-9,322
| -9% | -$689K | 1.93% | 13 |
|
|
2018
Q2 | $6.65M | Sell |
98,196
-5,018
| -5% | -$346K | 1.95% | 15 |
|
|
2018
Q1 | $7.48M | Sell |
103,214
-8,043
| -7% | -$612K | 2.17% | 13 |
|
|
2017
Q4 | $8.37M | Buy |
111,257
+5,486
| +5% | +$414K | 2.31% | 13 |
|
|
2017
Q3 | $8.14M | Sell |
105,771
-39
| -0% | -$2.94K | 2.54% | 10 |
|
|
2017
Q2 | $7.91M | Buy |
105,810
+123
| +0.1% | +$8.72K | 2.54% | 11 |
|
|
2017
Q1 | $7.03M | Sell |
105,687
-977
| -0.9% | -$65.1K | 2.19% | 16 |
|
|
2016
Q4 | $6.96M | Sell |
106,664
-2,288
| -2% | -$148K | 2.26% | 14 |
|
|
2016
Q3 | $7.71M | Sell |
108,952
-1,081
| -1% | -$78.8K | 2.5% | 12 |
|
|
2016
Q2 | $8.13M | Sell |
110,033
-2,057
| -2% | -$142K | 2.82% | 10 |
|
|
2016
Q1 | $7.28M | Buy |
112,090
+58,506
| +109% | +$3.98M | 2.6% | 12 |
|
|
2015
Q4 | $4.13M | Buy |
53,584
+5,162
| +11% | +$410K | 1.45% | 28 |
|
|
2015
Q3 | $3.99M | Sell |
48,422
-19,199
| -28% | -$1.71M | 1.75% | 20 |
|
|
2015
Q2 | $5.96M | Sell |
67,621
-341
| -0.5% | -$31.3K | 1.79% | 16 |
|
|
2015
Q1 | $6M | Sell |
67,962
-899
| -1% | -$79.7K | 1.75% | 15 |
|
|
2014
Q4 | $5.72M | Sell |
68,861
-418
| -0.6% | -$34.6K | 1.64% | 18 |
|
|
2014
Q3 | $5.84M | Sell |
69,279
-959
| -1% | -$77.6K | 1.68% | 18 |
|
|
2014
Q2 | $5.7M | Buy |
70,238
+4,771
| +7% | +$375K | 1.67% | 18 |
|
|
2014
Q1 | $4.99M | Sell |
65,467
-28
| -0% | -$2.04K | 2.35% | 15 |
|
|
2013
Q4 | $4.72M | Sell |
65,495
-12,964
| -17% | -$901K | 2.11% | 21 |
|
|
2013
Q3 | $5.39M | Buy |
78,459
+69,682
| +794% | +$4.61M | 1.63% | 21 |
|
|
2013
Q2 | $556K | Buy |
+8,777
| New | +$571K | 0.28% | 85 |
|
Other funds holding NVS
Fairfield, Bush & Co's NVS Position: Q1 2026 in Review
Fairfield, Bush & Co reduced its Novartis (NVS) stake by 10% in Q1 2026, selling an estimated $348K and leaving 19,344 shares worth $2.95M. The position accounts for 1.64% of the portfolio, ranked #15.
Fairfield, Bush & Co first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.37M in Q4 2017. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Fairfield, Bush & Co held 19,344 shares of Novartis worth $2.95M as of Q1 2026.
- Fairfield, Bush & Co sold 2,269 Novartis shares in Q1 2026, an estimated $348K.
- Novartis made up 1.64% of Fairfield, Bush & Co's portfolio in Q1 2026, its #15 holding.
- Fairfield, Bush & Co first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
- Fairfield, Bush & Co's Novartis position peaked at $8.37M in Q4 2017.
- 1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Fairfield, Bush & Co's 13F filing for Q1 2026, filed 12 May 2026.